Next Article in Journal
A New Cytotoxic 19-Nor-cardenolide from the Latex of Antiaris toxicaria
Previous Article in Journal
Synthesis and Antifungal Activity of 5-Chloro-6-Phenylpyridazin-3(2H)-one Derivatives
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Synthesis of Novel Asymmetric Zinc (II) Phthalocyanines Bearing Octadecyloxyl and Glucosyl Groups

State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian 116012, China
*
Author to whom correspondence should be addressed.
Molecules 2009, 14(9), 3688-3693; https://doi.org/10.3390/molecules14093688
Submission received: 23 July 2009 / Revised: 31 August 2009 / Accepted: 8 September 2009 / Published: 18 September 2009

Abstract

:
A novel asymmetric zinc (II) phthalocyanine substituted by one lipophilic octadecyloxyl group and three hydrophilic glucosyl groups was synthesized. Using Q-TOF MS, the major byproducts formed during the deprotection processes were identified. An improved procedure was worked out to convert these byproducts to the desired product in quantitative yield.

1. Introduction

Photodynamic therapy (PDT) has attracted increasing attention as a treatment for cancer in recent years [1,2,3,4,5,6,7,8], and photosensitizers play a critical role in this therapy. With a strong absorption at the red light region, the ability to generate singlet oxygen efficiently, and a long excitation wavelength which enables it to act deep under the skin, phthalocyanine is an ideal parent structure for a photosensitizer [9,10]. However, the poor aqueous solubility of phthalocyanine significantly limits its application in PDT. To improve its solubility, an ionic modification of phthalocyanine was made [11], but this failed to give the desired results. The resulting derivative also failed to meet the requirement of selective absorption by tumor cells. Compared to normal cells, tumor cells require more glucose as an energy supply. Additional glucose as a handle might assist penetration into target cells with the help of the functional glucose transporters on the cell membrane [12]. Thus, glucoconjugation of photosensitizers was expected to increase their selective absorption by tumor cells and their transportation through cell membranes. Glucoconjugated phthalocyanine was first reported in 1989 [13], followed in recent years by silicon(IV) phthalocyanines with one or two axial acetal-protected galactose substituents [14], glucose substituted zinc(II) phthalocyanine linked via the anomeric carbon [15], asymmetrical zinc(II) phthalocyanine with four galactose substituents [16], glycosylated zinc(II) phthalocyanines through O or S [17], octasubstituted galactose zinc(II) phthalocyanine [18], and amphiphilic Ni phthalocyanines bearing a hydrophilic galactose head facing six hydrophobic thiohexyl chains [19]. Amphiphilic capacity is an important factor in the design of photosensitizer due to the hydrophobic nature of the lipid membrane [20,21]. In our work, an asymmetrical zinc (II) phthalocyanine bearing three glucosyl groups and an octadecyloxyl group was designed and synthesized. Our synthetic methodology allows ready modulation of the amphiphilic capacity of phthalocyanines by changing the alkoxyl groups, which will provide a base for further studies in the impact of amphiphilic capacity on photosensitizer effects in PDT.

2. Results and Discussion

The preparation of asymmetric phthalocyanine 4 is shown in Scheme 1. Firstly, protected glucosyl phthalonitrile 1 (hydrophilic monomer) and octadecyloxyl phthalonitrile 2 (lipophilic monomer) were synthesized by nucleophilic substitution [13]. Phthalocyanine 3 was then obtained by statistical cross-condensation in the presence of zinc chloride and DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) under nitrogen at 100 ºC [22,23]. According to a probabilistic calculation, the highest theoretical yield is reached when the molar ratio of the hydrophilic monomer to the lipophilic monomer is 3:1. The reaction gave a series of phthalocyanines with different numbers of glucosyl and octadecyloxyl groups. The desired product 3 was isolated by silica gel column chromatography eluted with a gradient of ethyl acetate and toluene.
Scheme 1. Synthesis of [2(3), 9(10), 16(17)-tris(glucosyl)-23(24)-octadecyloxyl phthalocyaninato] zinc (II) (4).
Scheme 1. Synthesis of [2(3), 9(10), 16(17)-tris(glucosyl)-23(24)-octadecyloxyl phthalocyaninato] zinc (II) (4).
Molecules 14 03688 g002
The deprotection of compound 3 was initially carried out as follows: a sample of 3 in trifluoroacetic acid (TFA)/H2O (9/1 v/vwas stirred in the dark at 20 ºC for 30 min; then the reaction mixture was poured into toluene and rapidly evaporated under reduced pressure [16]. The product mixture was complicated and difficult to purify [23]. Thus it was analyzed by Q-TOF MS directly without further refinement. According to the Q-TOF results shown in Figure 1, in addition to the signal of the desired product 4 (m/z 1,379), there are several signals (m/z 1,419, 1,475 and 1,515) that may be attributed to compound 4 with one isopropylidene residue (M+40), TFA-esterified compound 4 (M+96) and TFA-esterified compound 4 with one isopropylidene residue (M+40+96), respectively. This indicates that the hydroxyl group had been esterified by TFA under the deprotection conditions. After several attempts at optimizing the deprotection conditions including changes in sample concentrations, the ratio of TFA/H2O and reaction temperature and time, esterification by TFA still occurred before the deprotection was complete.
Figure 1. Typical Q-TOF mass spectrum of raw products of compound 3 after deprotection reaction.
Figure 1. Typical Q-TOF mass spectrum of raw products of compound 3 after deprotection reaction.
Molecules 14 03688 g001
TFA esters undergo hydrolysis under alkaline conditions [24]. In our further attempts to optimize the synthesis, this was used to effect the deprotection of compound 3 by a two-step method. First, the sample was treated with TFA/H2O (9/1, v/v) to remove the isopropylidene group, then the mixture was stirred in pyridine/MeOH (1/30, v/v) to remove the trifluoroacetyl group. The desired compound 4 was then obtained in quantitative yield by evaporating the solution under reduced pressure.
The definitive characterization of compound 3 and 4 was achieved using Q-TOF MS. As a mixture of isomers, the 1H-NMR spectrum of compound 3 in a mixture of CDCl3 and pyridine-d5 (20/1, v/v) was in agreement with that of the phthalocyanine parent structure bearing protected glucosyl [24] or alkoxyl [25] groups with long carbon chains. It shows three broad signals between 9.45 and 8.65 ppm due to the resonance of Pc α-H or α’-H (Scheme 1) because there are two kinds of substituent linked to phthalocyanine. For the same reason, two broad signals between 7.95 and 7.45 ppm were assigned to the resonances of Pc β-H (Scheme 1). The 1H-NMR spectrum of compound 4 in DMSO-d6 was consistent with a phthalocyanine structure substituted by deprotected glucosyl [15,16] or alkoxyl [25] groups with long carbon chains, the signals corresponding to proton H-i of the glucosyl moieties (in α- and β- configurations) appeared at 6.75 and 6.95 ppm. UV-Vis spectrum of compound 4 in MeOH was a typical spectrum of phthalocyanine which had a sharp Q-band at 680 nm.

3. Experimental

3.1. General methods

For column chromatography, E. Merck 60G Silica Gel was used. 1H- and 13C-NMR spectra were recorded at ambient temperature using a Varian INOVA spectrometer. Chemical shift values were reported in d (ppm) relative to Me4Si. ESI-Q-Tof mass spectra (ESIMS) were measured using a Micromass UPLC/Q-Tof Mass Spectrometer. All reagents were of commercial quality and were purified according to general procedures.

3.2. Synthesis of [2(3),9(10),16(17)-tris(1,2:5,6-di-O-isopropylidene-a-D-glucofuranosyl)-23(24)-octadecyloxyl phthalocyaninato] zinc (II) (3)

Phthalonitrile 1 (2.4 g, 6 mmol), phthalonitrile 2 (0.8 g, 2 mmol) and ZnCl2 (0.3 g, 2 mmol) in DMAE (25 mL) were stirred at 100 ºC under a N2 atmosphere for 12 h. After cooling, the mixture was poured into water (500 mL) and the solid was filtered. The crude product was purified by chromatography over silica gel [eluent: EtOAc/toluene, 80:20] to give 3. Yield 0.8 g (25%). 1H-NMR (CDCl3 + pyridine-d5): δ = 9.45-8.65 and 7.95-7.45 (12H, Pc-H), 6.20 (3H, H-i), 5.46-5.35 (3H, H-iii), 5.06 (3H, H-ii), 4.81 (3H, H-v), 4.68-4.48 (3H, H-iv), 4.41-4.27 (8H, H-vi H-i’), 1.80-1.12 (68H, OCH3, CH2), 0.87 (3H, H-ii’); 13C-NMR (CDCl3 + pyridine-d5): δ = 158.85, 140.59, 140.45, 132.89, 131.39, 130.86, 130.21, 129.99, 129.71, 128.83, 128.11, 127.93, 118.55, 112.45, 109.38, 105.65, 82.80, 81.03, 72.60, 69.01, 67.38, 65.51, 62.12, 34.03, 31.91, 30.60, 29.73, 29.33, 29.12, 27.21, 27.03, 26.51, 26.38, 25.66, 25.42, 24.88, 22.66, 19.18, 14.07, 13.68; UV-vis (CHCl3) λmax (log ε): 347 (4.89), 616 (4.51), 681 (5.09) nm; HRMS (Q-TOF): m/z = 1620.9790 (M+H)+.

3.3. Synthesis of [2(3), 9(10), 16(17)-tris(glucosyl)-23(24)-octadecyloxyl phthalocyaninato] zinc (II) (4)

Phthalocyanine 3 (10 mg, 6.2 mmol) in TFA/H2O (9/1, v/v, 4 mL) was stirred in the dark at 0 ºC for 4 h, the reaction mixture was rapidly co-evaporated with toluene (50 mL) under reduced pressure, then the solid was stirred in the mixture DMF (0.1 mL) and pyridine/MeOH (1/30, v/v, 1mL) in the dark at 25ºC for 4 h. The product was obtained by evaporation under reduced pressure. 1H-NMR (DMSO-d6): δ = 9.40-8.80 and 7.94-7.70 (12H, Pc-H), 6.75 and 6.95 (3H, H-i), 5.72-3.45 (32H, Glu-H H-i’) 2.08-1.08 (32H, CH2), 0.81(3H, H-ii’); 13C-NMR (CDCl3 + pyridine-d5): δ = 158.24, 157.93, 157.62, 157.30, 153.17, 152.50, 140.33, 139.93, 131.28, 128.96, 128.13, 127.75, 122.70, 121.52, 119.82, 118.54, 115.56, 112.58, 109.02, 96.82, 92.55, 83.51, 76.51, 74.42, 72.17, 71.77, 69.65, 68.38, 60.97, 31.11, 28.85, 28.51, 25.58, 21.91, 21.31, 13.76; UV-Vis (MeOH) λmax (log ε): 349 (4.63), 613 (4.25), 680 (4.83) nm; HRMS (Q-TOF): m/z = 1379.3811 (M+H)+.

4. Conclusions

In summary, an asymmetric zinc (II) phthalocyanine with both lipophilic and hydrophilic groups has been synthesized and characterized. The TFA-esterified byproducts formed during the deprotection were characterized and converted into the final product by a two-step method which might find general application in the removal of isopropylidene groups from similar compounds. On the basis of this synthetic methodology, a series of asymmetric phthalocyanines with different lipophilic groups could be readily synthesized, which should provide great opportunities to study the impact of amphiphilic capacity on the effect of photosensitizers in PDT.

Acknowledgements

We gratefully acknowledge financial supports from the National Natural Science Funds for Distinguished Young Scholar of China (Grant No. 20525620) and the Program for Changjiang Scholars and Innovative Research Team in the University (IRT0711).
  • Samples Availability: Samples of the compounds are available from the authors.

References and Notes

  1. Dolmans, D.E.J.G.J.; Fukumura, D.; Jain, R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer 2003, 3, 380–387. [Google Scholar] [CrossRef]
  2. Ochsner, M. Photophysical and photobiological processes in the photodynamic therapy of tumors. J. Photochem. Photobiol. B 1997, 39, 1–18. [Google Scholar] [CrossRef]
  3. Dougherty, T.J.; Gomer, C.J.; Henderson, B.W.; Jori, G.; Kessel, D.; Korbelik, M.; Moan, J.; Peng, Q. Photodynamic therapy. J. Natl. Cancer I 1998, 90, 889–905. [Google Scholar] [CrossRef]
  4. His, R.A.; Rosenthal, D.I.; Glastein, E. Photodynamic therapy in the treatment of cancer: Current state of the art. Drugs 1999, 57, 725–734. [Google Scholar] [CrossRef]
  5. Adams, K.R.; Berembaum, M.C.; Bonnett, R.; Nizhnik, A.N.; Salgado, A. Second generation tumour photosensitisers: The synthesis and biological activity of octaalkyl chlorins and bacteriochlorins with graded amphiphilic character. J. Chem. Soc. Perkin Trans. 1 1992, 1465–1470. [Google Scholar]
  6. Bonnett, R.; Nizhnik, A.N.; White, R.D.; Berembaum, M.C. Porphyrin sensitizers in tumor phototherapy. Novel sensitizers of the chlorin and bacteriochlorin class with amphiphilic properties. J. Photochem. Photobiol. B 1990, 6, 29–37. [Google Scholar] [CrossRef]
  7. Bonnett, R. Photodynamic Action. In Advanced Chemistry Texts Chemical Aspects of Photodynamic Therapy; Gordon and Breach Science Publishers: London, UK, 2000; Volume 1, pp. 130–147. [Google Scholar]
  8. Zheng, G.; Potter, W.R.; Camacho, S.H.; Missert, J.R.; Wang, G.; Bellnier, D.A.; Henderson, B.W.; Rodgers, M.A.J.; Dougherty, T.J.; Pandey, R.K. Synthesis, photophysical properties, tumor uptake, and preliminary in vivo photosensitizing efficacy of a homologous series of 3-(1’-Alkyloxy)ethyl-3-devinylpurpurin-18-N-alkylimides with variable lipophilicity. J. Med. Chem. 2001, 44, 1540–1559. [Google Scholar] [CrossRef]
  9. Bonnet, R.; Martinez, G. Photobleaching of sensitizers used in photodynamic therapy. Tetrahedron 2001, 57, 9513–9547. [Google Scholar] [CrossRef]
  10. Macdonald, I.J.; Dougherty, T.J. Basic principles of photodynamic therapy. J. Porphyr. Phthalocya 2001, 5, 105–129. [Google Scholar] [CrossRef]
  11. Ogunsipe, A.; Nyokong, T. Photophysical and photochemical studies of sulphonated non-transition metal phthalocyanines in aqueous and non-aqueous media. J. Photochem. Photobiol. A 2005, 173, 211–220. [Google Scholar] [CrossRef]
  12. Brown, R.S.; Wahl, R.L. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer 1993, 72, 2979–2985. [Google Scholar] [CrossRef]
  13. Maillard, P.; Guerquin-Kern, J.L.; Momenteau, M. Glycoconjugated tetrapyrrolic macrocycles. J. Am. Chem. Soc. 1989, 111, 9125–9127. [Google Scholar] [CrossRef]
  14. Lee, P.P.S.; Lo, P.C.; Chan, E.Y.M.; Fong, W.P.; Ko, W.H.; Ng, D.K.P. Synthesis and in vitro photodynamic activity of novel galactose containing phthalocyanines. Tetrahedron Lett. 2005, 46, 1551–1554. [Google Scholar] [CrossRef]
  15. Alvarez, M.X.; Calvete, M.J.F.; Hanack, M.; Ziegler, T. The first example of anomeric glycoconjugation to phthalocyanines. Tetrahedron Lett. 2006, 47, 3283–3286. [Google Scholar] [CrossRef]
  16. Ribeiro, A.O.; Tomé, J.P.C.; Neves, M.G.P.M.S.; Tomé, A.C.; Cavaleiro, J.A.S.; Iamamotob, Y.; Torres, T. [1,2,3,4-Tetrakis(α/β-D-galactopyranos-6-yl)phthalocyaninato]zinc(II): A water-soluble phthalocyanine. Tetrahedron Lett. 2006, 47, 9177–9180. [Google Scholar]
  17. Xavier, Á.M.; Mario, J.F.C.; Michael, H.; Thomas, Z. Expeditious Synthesis of Glycosylated Phthalocyanines. Synthesis 2007, 14, 2186–2192. [Google Scholar]
  18. Zafar, I.; Michael, H.; Thomas, Z. Synthesis of an octasubstituted galactose zinc(II) phthalocyanine. Tetrahedron Lett. 2009, 50, 873–875. [Google Scholar] [CrossRef]
  19. Ufuk, K.; Mahmut, A.E.; Fabienne, D.; Vefa, A. Amphiphilic galactosylated phthalocyanines. J. Porphyr. Phthalocya 2008, 12, 1090–1095. [Google Scholar] [CrossRef]
  20. Drain, C.M.; Christensen, B.; Mauzerall, D.C.P. Photogating of ionic currents across a lipid bilayer. Proc. Natl. Acad. Sci. USA 1998, 86, 6959–6962. [Google Scholar]
  21. Drain, C.M.; Mauzerall, D.C. Photogating of ionic currents across lipid bilayers. Hydrophobic ion conductance by an ion chain mechanism. Biophys. J. 1992, 63, 1556–1563. [Google Scholar] [CrossRef]
  22. Tomoda, H.; Asito, S. Phosphonates and thiophosphonates as sulfate surrogates: synthesis of estrone 3-methylthiophosphonate, a potent inhibitor of estrone sulfatase. Chem. Lett. 1983, 3, 313–318. [Google Scholar] [CrossRef]
  23. Choi, C.F.; Huang, J.D.; Lo, P.C.; Fong, W.P.; Ng., D.K.P. Glycosylated zinc(II) phthalocyanines as efficient photosensitisers for photodynamic therapy. Synthesis, photophysical properties and in vitro photodynamic activity. Org. Biomol. Chem. 2008, 6, 2173–2181. [Google Scholar] [CrossRef]
  24. Takatani, M.; Matsuo, I.; Ito, Y. Pentafluoropropionyl and trifluoroacetyl groups for temporary hydroxyl group protection in oligomannoside synthesis. Carbohydr. Res. 2003, 338, 1073–1081. [Google Scholar] [CrossRef]
  25. Chauhan, S.; Kumari, P.; Agarwal, S. Efficient synthesis of transition-metal phthalocyanines in functional ionic liquids. Synthesis 2007, 23, 3713–3721. [Google Scholar]

Share and Cite

MDPI and ACS Style

Zhang, P.; Zhang, S.; Han, G. Synthesis of Novel Asymmetric Zinc (II) Phthalocyanines Bearing Octadecyloxyl and Glucosyl Groups. Molecules 2009, 14, 3688-3693. https://doi.org/10.3390/molecules14093688

AMA Style

Zhang P, Zhang S, Han G. Synthesis of Novel Asymmetric Zinc (II) Phthalocyanines Bearing Octadecyloxyl and Glucosyl Groups. Molecules. 2009; 14(9):3688-3693. https://doi.org/10.3390/molecules14093688

Chicago/Turabian Style

Zhang, Pei, Shufen Zhang, and Gang Han. 2009. "Synthesis of Novel Asymmetric Zinc (II) Phthalocyanines Bearing Octadecyloxyl and Glucosyl Groups" Molecules 14, no. 9: 3688-3693. https://doi.org/10.3390/molecules14093688

APA Style

Zhang, P., Zhang, S., & Han, G. (2009). Synthesis of Novel Asymmetric Zinc (II) Phthalocyanines Bearing Octadecyloxyl and Glucosyl Groups. Molecules, 14(9), 3688-3693. https://doi.org/10.3390/molecules14093688

Article Metrics

Back to TopTop